Mirion Technologies, Inc. MIR R2KR3K
Company Overview
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Why Investors Should Care
Revenue has grown at a 13.2% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $925.40M (+7.5% YoY); net profit $28.80M.
- Trailing 12 Months Year-on-year growth — revenue +19.7%, earnings +0.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.19% |
| 1 Year: | 19.70% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 0.00% |
Stock Price Performance
| 1 Year: | -23.50% |
| 6 Months: | -17.58% |
| 3 Months: | -0.88% |
| 1 Month: | +12.72% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)63.08 · Neutral
P/E of 188.11 is above the sector median of 27.38 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 188.1.
- Trading 43.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MIR Mirion Technologies, Inc. R2KR3K | 16.93 | 188.11 | $4.12B | 0.00% | 1.57% | 1.51% | 13.19% | - |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 147.95 | -134.50 | $1.12T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 813.94 | 35.05 | $374.15B | 0.76% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 337.12 | 39.85 | $349.78B | 0.50% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 200.79 | 35.41 | $270.62B | 1.31% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 941.95 | 26.98 | $250.87B | 0.20% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 693.53 | 39.29 | $187.33B | 1.05% | 12.53% | 18.35% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 291.88 | 23.83 | $173.40B | 1.92% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 212.25 | 76.08 | $167.63B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 166.20M | 180.00M | 144.30M | 154.10M | 163.20M | 175.80M | 160.90M | 182.10M | 197.20M | 191.20M | 192.60M | 207.10M | 206.80M | 202.00M | 222.90M | 223.10M | 257.60M | 266.80M |
| Gross Profit | - | - | - | 62.50M | 79.60M | 61.90M | 53.90M | 64.40M | 79.00M | 69.80M | 79.10M | 88.00M | 80.80M | 87.10M | 97.40M | 92.90M | 96.10M | 102.50M | 104.50M | 119.10M | 133.10M |
| Operating Income | - | - | - | -8.90M | 4.70M | -8.90M | -22.90M | -33.60M | -74.60M | -27.60M | -13.60M | -10.60M | -11.10M | -4.90M | 2.30M | -1.60M | 8.70M | 9.90M | 7.40M | 3.70M | 17.90M |
| Net Income | 0 | -46.40K | -32.13M | -40.70M | -53.90M | -46.70M | -22.20M | -17.70M | -58.60M | -47.10M | -41.90M | -27.70M | -12.10M | -25.80M | -11.70M | -13.60M | 300.00K | 8.30M | 2.90M | -3.40M | 7.70M |
| Diluted EPS | - | - | - | -6.18 | -8.14 | -7.01 | -0.12 | -0.10 | -0.32 | -0.26 | -0.22 | -0.14 | -0.06 | -0.13 | -0.06 | -0.07 | 0.00 | 0.03 | 0.01 | -0.01 | 0.03 |
| R&D Expense | - | - | - | 11.00M | 8.20M | 8.50M | 6.70M | 7.10M | 7.40M | 8.00M | 7.60M | 8.40M | 7.90M | 7.90M | 8.80M | 10.20M | 8.70M | 10.00M | 10.10M | 9.60M | 10.10M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2019 | Dec 2019 | Jun 2020 | Dec 2020 | Jun 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 440.10M | - | 478.20M | - | 611.60M | 717.80M | 800.90M | 860.80M | 925.40M |
| Gross Profit | 188.20M | - | 197.00M | - | 251.80M | 310.10M | 356.40M | 399.70M | 438.60M |
| Operating Income | 28.80M | - | 23.00M | - | 11.20M | -297.80M | -21.90M | 24.80M | 51.50M |
| Net Income | -122.00M | -341 | -119.10M | -1.04M | -158.30M | -276.90M | -96.90M | -36.10M | 28.80M |
| Diluted EPS | -19.36 | - | -18.45 | - | -24.18 | -1.53 | -0.49 | -0.18 | 0.11 |
| R&D Expense | 14.00M | - | 15.90M | - | 29.40M | 30.30M | 31.70M | 35.00M | 38.90M |
Balance Sheet (Annual)
Figures in USD.
| Metric | May 2018 | Jun 2018 | Dec 2018 | Jun 2019 | Dec 2019 | Jun 2020 | Dec 2020 | Jun 2021 | Oct 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | 5.00K | 1.24B | 751.32M | 1.55B | - | 3.12B | 2.74B | 2.72B | 2.64B | 3.59B |
| Total Equity | 0 | -448.80M | 4.71K | -587.70M | 4.36K | -718.70M | 5.00M | -841.60M | -944.10M | 1.69B | 1.40B | 1.48B | 1.51B | 1.87B |
| Cash & Equivalents | - | - | - | 35.80M | - | 118.40M | - | 101.10M | 101.80M | 84.00M | 73.50M | 128.80M | 175.20M | 412.30M |
| Long Term Debt | - | - | - | - | - | 669.80M | - | 885.70M | - | 806.80M | 801.50M | 684.70M | 685.20M | 443.10M |
| Total Liabilities | - | - | - | - | 636 | 1.96B | 27.59M | 2.39B | - | 1.33B | 1.27B | 1.17B | 1.08B | 1.67B |
| Current Liabilities | - | - | - | - | 636 | 183.50M | 1.34M | 188.20M | - | 221.00M | 244.30M | 265.70M | 263.40M | 316.10M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2019 | Dec 2019 | Jun 2020 | Dec 2020 | Jun 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.70M | 0 | 39.50M | -945.35K | 53.60M | 39.40M | 95.20M | 99.10M | 143.30M |
| Investing Cash Flow | -25.60M | - | -75.60M | - | -313.30M | -39.50M | -64.70M | -43.70M | -694.60M |
| Financing Cash Flow | 15.00M | 0 | 118.90M | 751.39M | 239.00M | -7.00M | 22.60M | -3.30M | 775.90M |
| Capital Expenditure | -16.50M | - | -19.90M | - | -23.20M | -34.20M | -37.10M | -48.80M | -36.40M |
| Free Cash Flow | -1.80M | - | 19.60M | - | 30.40M | 5.20M | 58.10M | 50.30M | 106.90M |
| Share Buybacks | - | - | - | - | 0 | 0 | 0 | 0 | 49.60M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2019 | Dec 2019 | Jun 2020 | Dec 2020 | Jun 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 42.8% | - | 41.2% | - | 41.2% | 43.2% | 44.5% | 46.4% | 47.4% |
| Operating Margin % | 6.5% | - | 4.8% | - | 1.8% | -41.5% | -2.7% | 2.9% | 5.6% |
| Net Margin % | -27.7% | - | -24.9% | - | -25.9% | -38.6% | -12.1% | -4.2% | 3.1% |
| ROE % | 20.8% | -7.8% | 16.6% | -20.8% | 18.8% | -19.8% | -6.5% | -2.4% | 1.5% |
| ROCE % | - | - | 2.2% | - | 0.8% | -11.9% | -0.9% | 1.0% | 1.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 15.73% | 38.26M | $550.98M |
| 2 | Vanguard Portfolio Management LLC | 7.47% | 18.18M | $261.79M |
| 3 | T. Rowe Price Investment Management, Inc. | 5.87% | 14.29M | $205.75M |
| 4 | Vanguard Capital Management LLC | 4.36% | 10.61M | $152.84M |
| 5 | Goldman Sachs Group Inc | 4.28% | 10.41M | $149.86M |
| 6 | State Street Corporation | 4.08% | 9.92M | $142.90M |
| 7 | Alyeska Investment Group, L.p. | 3.92% | 9.53M | $137.30M |
| 8 | Cooperman, Leon G. | 3.45% | 8.38M | $120.72M |
| 9 | FMR, LLC | 3.01% | 7.33M | $105.54M |
| 10 | Congress Asset Management Co | 2.75% | 6.69M | $96.27M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MIR
Why Mirion (MIR) Stock Is Trading Up Today - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQRGw4ckJ0azVEeFdkOENDeUNRaTB2MkQ3bmotWFBucGZHdV8wR2JQOWQtS094di11VlBIajZUQ1YweEYtREEzQWJQTHVmQWs3M0w1ZDlZMmNBUi05WHc5bkQwTTJCc1A0YmJSU2hpTUoxcVl3WTZYbFRfVXBDWEZ0S1JSZ0Y1OVNHUTRqUz…
$MIR stock is up 7% today. Here's what we see in our data. - quiverquant.com
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQMWlRRTFqS05LYk1hWjB5bHhobkRxMkJQTkJSSEcxN2Fqd1pJcmNVa2k0UG1IZVB1VGlQZFlETmNETDQzVm44Rnh5QWRGbm5Bd0kzNkRsZi05dUd2SjJHTndPQkduZTJVenE0R3FYYXc1SnJ1Nng1VkVVT00tV1lYNV9XdWZrUmZUQjVkND…
Mirion Technologies Inc (MIR) Stock Up 7.6% but GF Value Says Ov - GuruFocus
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNZ2l6ZzdFVzN6WXRTY2dWWEVhV045SHlCQ2kyc0FSdjRISXlGZjE0VkRaVUpINk1nOHc0U2pSVVBPRy1ZMWlyX0t1S3BsUmtvYllha0hwT09QTG5HYmhhaTQ5SzFFMzJkNVdLS2FvbHFtMGFRcDZEczFpUXZ6ZXJDNlBsckphM3ZPcm8weT…
Why Mirion Technologies (MIR) Is Up 17.6% After New Buyback Plan And Jefferies Coverage Initiation - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQdXg1RTBDVXpNNktCQ3p4OUt0cndaWk1nc3NUcS15akxOQVkzeFhyS3lkSGx5YkFFUnJoZkR5VHctMU1UYm1BM1lXY2VzWmNtbEs4Q1pTaUZIZ1pDeWFfQl9tb01sVDdWZWxQM1hxbE9hQUVQZ1g1bW05NEtCUlVyM2xiTUIzdUhLUEFuMW…
2 Stocks Under $50 to Target This Week and 1 Facing Challenges - StockStory
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxOcl9kVWtUOEk2YnBHVzFGN2NXdDJRUWFBcVZFalZaS2lSRFZWaTJPaFJwSUhqSDA4NzRrclhsX00xaHNtVlN0UFlaNUJoeGxfUnA3R0pFNUVnbjBhb3pBNGx0c3VrdVNPLVZSNGRPX1lkYVFBY1M3d2FOdC1HanlINzVwRkdzNmJKVTBERU…
Mirion Technologies (MIR) CFO boosts stake with 20,000-share buy - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNRU9aOEJobG1uSXlMV01OWmh2cWYxRWdKWmdJQ1hUc2JQdWVHa0NGcnBoTFpNTzQ5R2lLeWRNMXVzaU0yQ1QxMjEyXzRjLXRXa1J3WUJUQzVTOGprMzhXMjM2OHJVSmJRc2RYbG1ESDRnWlV4cXV5cmhWeVBwY2dUY010S2VueXI5MDFoOT…
MIR — Frequently Asked Questions
What is the current share price of Mirion Technologies, Inc. (MIR)?
As of 2026-09-07 16:24 PDT, Mirion Technologies, Inc. (MIR) trades at $16.93 on NYSE. Its 52-week range is $14.40 to $29.75.
What is the market capitalisation of MIR?
Mirion Technologies, Inc. (MIR) has a market capitalisation of $4.12B on NYSE.
What is the P/E ratio of MIR?
MIR trades at a trailing price-to-earnings (P/E) ratio of 188.11. The industry average P/E is 27.38. Its price-to-book (P/B) ratio is 2.09.
What is the return on equity (ROE) of MIR?
MIR has a return on equity (ROE) of 1.51%. Its return on capital employed (ROCE) is 1.57%.
Is MIR a good stock to buy?
This page provides a data-driven analysis of Mirion Technologies, Inc. (MIR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.